Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)
China flag China · Delayed Price · Currency is CNY
5.85
-0.09 (-1.52%)
Nov 6, 2026, 10:25 AM CST

SHE:300942 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
477.51392.84293.4481.75247.45342.21
Short-Term Investments
----181.91-
Trading Asset Securities
66.59235.3302.92120.03-340.21
Cash & Short-Term Investments
544.11628.13596.31601.78429.36682.42
Cash Growth
-8.53%5.34%-0.91%40.16%-37.08%80.01%
Accounts Receivable
125.24111.3394.1176.284.0397.37
Other Receivables
5.594.45.83.3615.176.5
Receivables
130.83115.7499.9179.5699.2103.87
Inventory
75.8354.7740.4331.46100.6193.86
Other Current Assets
24.3219.1714.9624.8745.2517.49
Total Current Assets
775.09817.81751.62737.67674.42897.64
Property, Plant & Equipment
563.38578.27562.9426.52324.64143.44
Long-Term Investments
67.7383.52100.69145.18195.7621.94
Other Intangible Assets
35.8937.3539.2441.3942.442.6
Long-Term Accounts Receivable
----3.61-
Long-Term Deferred Tax Assets
14.327.050.083.0614.97.4
Long-Term Deferred Charges
0.290.541.681.9314.311.42
Other Long-Term Assets
--0.960.5912.4228.07
Total Assets
1,4571,5251,4571,3561,2821,153

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
38.8172.9658.7677.3565.1155.66
Accrued Expenses
18.5626.223.0823.9439.4546.73
Short-Term Debt
-21----
Current Portion of Long-Term Debt
13.4313.5541.65.475.18-
Current Portion of Leases
---9.2818.614
Current Income Taxes Payable
1.534.550.050.010.019.74
Current Unearned Revenue
22.2517.2525.118.6566.6127.59
Other Current Liabilities
9.415.23.362.224.822.91
Total Current Liabilities
103.99160.7151.96136.93199.78156.63
Long-Term Debt
439.96413426.39345.7856.32-
Long-Term Leases
---5.3439.2527.12
Long-Term Unearned Revenue
38.1541.096.516.5420.3322.19
Other Long-Term Liabilities
2.082.082.083.022.08-
Total Liabilities
584.18616.87586.92507.61317.75205.94

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
405.08405.07401.32400.86400.86400.86
Additional Paid-In Capital
221.67221.56190.22186.59178.7141.91
Retained Earnings
178.51215.89209.14192.02385.43402.28
Comprehensive Income & Other
60.5361.5668.3369.52-0.09-0.28
Total Common Equity
865.79904.08869.01848.99964.89944.76
Minority Interest
6.733.61.24-0.27-0.191.82
Shareholders' Equity
872.52907.68870.24848.73964.7946.58
Total Liabilities & Equity
1,4571,5251,4571,3561,2821,153

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
453.39447.55467.98365.87119.3441.12
Net Cash (Debt)
90.72180.59128.33235.91310.02641.31
Net Cash Growth
-39.67%40.72%-45.60%-23.91%-51.66%69.17%
Net Cash Per Share
0.200.390.300.590.781.63
Filing Date Shares Outstanding
405.87405.07401.32400.86400.86400.86
Total Common Shares Outstanding
405.87405.07401.32400.86400.86400.86
Working Capital
671.1657.11599.66600.74474.64741.02
Book Value Per Share
2.132.232.172.122.412.36
Tangible Book Value
829.9866.73829.76807.6922.49902.16
Tangible Book Value Per Share
2.042.142.072.012.302.25
Buildings
-553.85330.0315.8715.8710.24
Machinery
-97.9187.0990.58106.5172.08
Construction In Progress
-2.26199.79356.63190.8751.34